New pill TJ0113 hopes to lift depression in 8 weeks
Symptom relief
Recruiting now
This phase 2 trial tests an experimental drug called TJ0113 for people with depression. About 150 adults aged 18 to 65 will take either 200 mg or 400 mg of TJ0113 or a placebo daily for 8 weeks. Researchers will measure changes in depression symptoms using a standard rating scale…
Phase: PHASE2 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC